2012
DOI: 10.4161/cc.22222
|View full text |Cite
|
Sign up to set email alerts
|

Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
20
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(22 citation statements)
references
References 49 publications
2
20
0
Order By: Relevance
“…Previous epidemiologic studies have reported the increased risk in the incidence of colorectal cancer among patients receiving calcineurin inhibitors as immunosuppressants, probably due to an impaired calcineurin-dependent tumor immunosurveillance (40,41). Moreover, a previous report suggested that FK506 promotes colorectal cancer cell line growth, although cyclosporin A inhibits the tumor growth independent of the calcineurin pathway (38). In contrast, several reports have indicated that calcineurin and NFAT have oncogenic functions, and blocking them inhibits colorectal cancer cell growth (26,42).…”
Section: Discussionmentioning
confidence: 80%
See 1 more Smart Citation
“…Previous epidemiologic studies have reported the increased risk in the incidence of colorectal cancer among patients receiving calcineurin inhibitors as immunosuppressants, probably due to an impaired calcineurin-dependent tumor immunosurveillance (40,41). Moreover, a previous report suggested that FK506 promotes colorectal cancer cell line growth, although cyclosporin A inhibits the tumor growth independent of the calcineurin pathway (38). In contrast, several reports have indicated that calcineurin and NFAT have oncogenic functions, and blocking them inhibits colorectal cancer cell growth (26,42).…”
Section: Discussionmentioning
confidence: 80%
“…The effect of calcineurin in colorectal cancer remains controversial, and calcineurin may act as both a tumor suppressor while also inducing oncogenic activity in colorectal cancer (26,38,39). Previous epidemiologic studies have reported the increased risk in the incidence of colorectal cancer among patients receiving calcineurin inhibitors as immunosuppressants, probably due to an impaired calcineurin-dependent tumor immunosurveillance (40,41).…”
Section: Discussionmentioning
confidence: 99%
“…2, NFATc1 and especially NFAT5 were highly expressed in PASMCs, but the roles of these proteins remain unclear. In addition, some researchers are of the opinion that CsA affects cell apoptosis in an NFAT-independent manner or by decreasing STAT3/NF-κB activation [53,54]. It is well known that NFAT is the most important substrate of CaN.…”
Section: Discussionmentioning
confidence: 99%
“…We did not observe effects of NFAT inhibition on expression of HNF1B. Recently, Werneck et al 26 suggested that the CNI CsA may have biological effects independent of the TGFβ-, NFAT-, NFΚB-, and PI3K/mTOR pathways. How CsA and tacrolimus can alter HNF1B mRNA expression remains to be determined but our result prompts treating HNF1B patients receiving solid organ transplant with an immunosuppressive regimen avoiding CNIs.…”
mentioning
confidence: 67%